bexmarilimab
faron pharmaceuticals
['melanoma', 'faron']
faron pharmaceuticals presents results from pd-1 blockade refractory melanoma cohort of matins trial at 19th international congress of the society for melanoma research 
Press- and earnings-releases in English and Swedish.